NA
Natac Natural Ingredients, S.A.
NAT.MC · BME
0.56 € -3.48% (-0.02 €)
1M -6.78%
Market Cap 239.7M €
P/E Ratio 223.99x
Div. Yield -
ROE 2.50%
Bulios Fair Price
0.39 €
29.7% downside
Current Price
0.56 €
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NAT.MC is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
10 /100
Expensive EV/EBITDA 26.27x
P/S 4.99x
P/B 5.33x
Growth
54 /100
Stable Rev. growth 28.90%
EPS growth 53.83%
Book val. growth N/A
Profitability
29 /100
Weak Net margin 2.23%
Op. margin 8.58%
FCF margin 15.38%
Quality
18 /100
Poor ROE 2.50%
ROA 0.76%
Asset turnover 0.34x
Debt
20 /100
High Current ratio 0.58x
Int. coverage 0.88x
Net debt/EBITDA 5.55x
Stability
58 /100
Moderate Rev. volatility 9.22%
EPS volatility 336.00%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NAT.MC
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Antonio Ángel Delgado Romero
Employees
181
Headquarters
Getafe